Neuronetics Inc (NASDAQ: STIM) kicked off on Monday, up 8.12% from the previous trading day, before settling in for the closing price of $3.57. Over the past 52 weeks, STIM has traded in a range of $0.52-$5.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.71% over the past five years. While this was happening, its average annual earnings per share was recorded 74.08%. With a float of $36.77 million, this company’s outstanding shares have now reached $65.82 million.
Let’s look at the performance matrix of the company that is accounted for 716 employees. In terms of profitability, gross margin is 63.51%, operating margin of -43.29%, and the pretax margin is -53.68%.
Neuronetics Inc (STIM) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Neuronetics Inc is 44.39%, while institutional ownership is 25.78%. The most recent insider transaction that took place on May 12 ’25, was worth 826,074. In this transaction EVP, CFO and Treasurer of this company sold 193,460 shares at a rate of $4.27, taking the stock ownership to the 416,593 shares. Before that another transaction happened on May 13 ’25, when Company’s EVP, CFO and Treasurer sold 6,540 for $4.16, making the entire transaction worth $27,206. This insider now owns 410,053 shares in total.
Neuronetics Inc (STIM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 74.08% per share during the next fiscal year.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Take a look at Neuronetics Inc’s (STIM) current performance indicators. Last quarter, stock had a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Neuronetics Inc (NASDAQ: STIM) saw its 5-day average volume 0.76 million, a negative change from its year-to-date volume of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 91.38%.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 26.69%, which indicates a significant decrease from 96.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was lower than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.87, while its 200-day Moving Average is $2.83. Nevertheless, the first resistance level for the watch stands at $3.98 in the near term. At $4.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.33. If the price goes on to break the first support level at $3.64, it is likely to go to the next support level at $3.42. Assuming the price breaks the second support level, the third support level stands at $3.29.
Neuronetics Inc (NASDAQ: STIM) Key Stats
The company with the Market Capitalisation of 255.20 million has total of 66,114K Shares Outstanding. Its annual sales at the moment are 74,890 K in contrast with the sum of -43,710 K annual income. Company’s last quarter sales were recorded 31,980 K and last quarter income was -12,680 K.
